Docere 2
Docere 2
7/14/2021 Docere 2
DISCLAIMER AND FORWARD-LOOKING INFORMATION
• CONFIDENTIALITY AND USE: This corporate presentation and the information contained herein (the “Presentation”) is proprietary and for authorized use only. It is being provided for the use of prospective investors with
the express understanding that, without the prior permission in writing from Docere App Inc. the investor will not copy this Presentation or any portion of it or use any information contained herein for any purpose other
than evaluating a potential investment in securities of Docere App. This Presentation provides general background information about the activities of the Company. Information disclosed in this Presentation is current as
of October [], 2021, except as otherwise provided herein, the Company does not undertake or agree to update this Presentation after the date hereof. All information is derived solely from management of the Company
and otherwise publicly available third-party information that has not been independently verified by the Company. Further, it does not purport to be complete nor is it intended to be relied upon as advice (legal,
financial, tax or otherwise) to current or potential investors. Each prospective investor should contact his, her or its own legal adviser, independent financial adviser or tax adviser for legal, financial or tax advice. No
person has been authorized to give any information or make any representations other than those contained in this Presentation and, if given and/or made, such information or representations must not be relied upon
as having been so authorized. FORWARD LOOKING-INFORMATION: This Presentation contains “forward-looking information” within the meaning of applicable Canadian securities laws. This information and these
statements, referred to herein as “forward looking statements”, are made as of the date of this Presentation or as of the date of the effective date of information described in this Presentation, as applicable. Forward-
looking statements relate to future events or future performance and reflect current estimates, predictions, expectations or beliefs regarding future events and include, without limitation, statements with respect to: (a)
the prospectus and growth trajectory of the virtual healthcare industry; (b) general business and economic conditions; (c) expectations as to future operations of the Company; (d) the Company’s ability to maintain
adequate systems and software’s to meet customer demand; (e) the Company’s anticipated financial performance and ability to generate revenue; (f) ability to meet current and future obligations; (g) the availability of
financing on reasonable terms; (h) competition in the market and products offered by the Company’s competitors; (i) financial results, future financial position and expected growth of revenue and net income of the
Company; (j) general statements about the Company’s business strategy; (k) expected operating costs, general and administrative costs, costs of services and other costs and expenses; and (l) broader industry trends.
Generally, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "expects", or "does not expect", "is expected", "budget", "scheduled", "estimates", “projects”,
“targets”, "forecasts", "intends", "anticipates", or "does not anticipate", or "believes" or variations (including negative and grammatical variations) of such words and phrases or state that certain actions, events or
results “likely”, "may", "could", "would", "might", or "will be taken", "occur", or "be achieved". Forward-looking information is based on the opinions and estimates of management at the date the information is made,
and is based on a number of assumptions and is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to
be materially different from those expressed or implied by such forward looking information, including without limitation: (i) the Company is subject to changes in Canadian laws, regulations and guidelines which could
adversely affect the Company’s future business and financial performance; (ii) the Company may not be able to effectively manage its growth and operations, which could materially and adversely affect its business; (iii)
the Company may be unable to obtain additional financing on acceptable terms or not at all; (iv) the Company may become subject to litigation, including possible product liability claims, which may have a material
adverse effect on the Company’s reputation, business, results from operations and financial condition; (v) the Company faces competition from other companies where it will conduct business and those companies may
have a higher capitalization, more experienced management or may be more mature as a business; (vi) the Company is reliant on management and retaining key personnel; (vii) an investment in the securities in the
Company is speculative and could result in the loss of an investor’s entire investment; (ix) value of the Company’s securities is determined by management; (x) intellectual property risks in obtaining and maintaining
patent and IP protections for the Company’s licenced technology, trademarks, other proprietary assets; (xi) general market and economic conditions; and (xii) volatility and systemic risks from the COVID-19 pandemic
and resulting governmental regulatory responses. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking
information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such information will prove to be accurate, as actual results and future events
could differ materially from those anticipated in such information. Accordingly, readers should not place undue reliance on forward-looking information. Teledact and its directors, officers and employees disclaim any
obligation to update any forward-looking statements, whether as a result of new information, future events or results or otherwise, except as required by applicable law. Accordingly, current and potential investors
should not place undue reliance on forward-looking statements due to the inherent uncertainty therein. All forward-looking information is expressly qualified in its entirety by this cautionary statement. An investor
should read this Presentation with the understanding that the Company’s actual future results may be materially different from what is expected. FUTURE ORIENTED FINANCIAL INFORMATION: To the extent any forward-
looking information in this presentation constitutes “future-oriented financial information” or “financial outlooks” within the meaning of applicable Canadian securities laws, the reader is cautioned that this information
may not be appropriate for any other purpose and the reader should not place undue reliance on such future-oriented financial information and financial outlooks. Future-oriented financial information and financial
outlooks, as with forward-looking information generally, are, without limitation, based on the assumptions and subject to the risks set out above. The actual financial position and results of operations may differ
materially from management’s current expectations and, as a result, the Company’s revenue and profitability may differ materially from the revenue and profitability profiles provided in this presentation. Such
information is presented for illustrative purposes only and may not be an indication of the Company’s actual financial position or results of operations. The Company uses a number of financial measures to assess its
performance. Some of these measures are not calculated in accordance with Generally Accepted Accounting Principles (GAAP), which are based on International Financial Reporting Standards (IFRS) as issued by the
International Accounting Standards Board (IASB), are not defined by GAAP and do not have standardized meanings that would ensure consistency and comparability among companies using these measures. The
Company believes that certain non-GAAP measures are useful in assessing ongoing business performance and provide readers with a better understanding of how management assesses performance. Readers are
cautioned that these non-GAAP financial measures should not be considered in isolation or as a substitute for measures of performance prepared in accordance with IFRS. Non-GAAP measures presented include earnings
include earnings before interest and taxes (EBIT) and earnings before interest, taxes, depreciation and amortization (EBITDA).
3
Our motto
7/14/20XX Docere 4
4.6 million Canadians reported that they
do not have a regular health care provider
7/14/20XX Docere 5
PROBLEM
PROBLEM
MAIN PROBLEM COSTS
The queues in hospitals are very long as they Long wait at the hospital cost more than one
are overcrowded with patients. million Canadians more than $2 billion in lost
There is need for a safe(unhackable) and fast wages and productivity last year, according to a
way of paying doctors new study by the Fraser Institute. That’s about
IDEAL CUSTOMER PROFILE(ICP) $2,000 per patient.
Doctors who don’t use physical examination, On the other hand, like any business, private clinics
there is no need for the patient to come to the when dealing with long lines,lose a lot of
hospital to be checked, when both parties can do patients(customers). Koehoorn et al. studied cost
this from home. of care and return-to-work time in British
Columbia,and found out that privately founded
ENVIRONMENTAL TREND health care doesn’t reduce wait-times.
People after the Covid-19 pandemic, started to USABILITY
become more passive,also due to companies like: Patients and doctors need a very user-friendly
Uber Eats, Amazon etc. and also the digitization of platform
products and services is booming.
7/14/2021 Docere
SOLUTION
UNIQUE SELLING PROPOSITION(USP)
Our platform will maximally reduce queues in hospitals, enabling the
Canadian citizens to save a lot of money, and doctors to not use their
patients(clients).
TARGET AUDIENCE
Patients who need doctors that don’t use physical examination.
EASY TO USE
A simple platform that any age can use it.
7/14/2021 Docere 7
Let's see what the doctors have to say
Docere is changing Canada’s private Homeopathy is a really interesting branch of medicine, because
medical sector. unlike any other specialty, with my patients I have to be in
I will use Docere to communicate with my constant communication.
patients,especially after the changes that Luka is a wonderful boy and when he told me about Docere, I
Covid-19 has made to our lives. liked it very much and I can't wait to use this app.
-Ferenczi Zoltan M.D(family doctor) -Laura Vigras N.D(homeopath)
Docere 8
BUSINESS MODEL
7/14/20XX Docere 9
Market Validation
Would this platform be helpful to you?
1400
1,300
360,000
1200
1000 1,000
7/14/20XX Docere 11
HOW CAN YOU PAY?
7/14/20XX Docere 12
DOCERE MARKET SIZE
7/14/20XX Docere 13
OUR COMPETITION
DOCERE COMPETITORS
7/14/20XX Docere 14
OUR COMPETITION
Disruptive
DOCERE
Teladoc
Maple Teams
Zoom
Legacy
7/14/20XX Docere 15
MEET THE MANAGEMENT TEAM
-Luka Lamaj is a 21-years old entreprener the founder and CEO of -Ervis Lilaj is our VR specialist with an extraordinary
Docere is a 2nd-year Biochemistry student at Bishop's experience in the field of VR when he worked with Unity
University.He comes from a small country in Eastern Europe called on several projects for multiplayer and single-player
Albania.Luka is an entrepreneur and founder of 3 games.
ventures:Docere,Cool Historians, and Laval NFT. He studied at the Technische Universität Dresden where
It has appeared 3 times on Albanian TV Channels with a huge he received his bachelor's and master's degrees in
audience,and also Canadian and Albanian magazines have written Computer Science.
about him and his ventures. He is currently working with auto-pilot feature on cars
and as software engineer for NORDSYS GmbH.
CEO & Co-Founder VR Expert
7/14/2021 Docere 16
Our Go-To Market Strategy
We are currently applying the Marketing
philosophy created by Tesla that is 0 money spent
in Marketing.The strategy is based on “Word of
mouth” and Social Media.
And our LTV:CAC goal is to push it through 3:1.
The Customer Retention Rate goal is to be over
90% over the 7 months we forecasted before.
7/14/20XX Docere 17
Blue Ocean Strategy+Zero Marginal Cost
7/14/20XX Docere 20
Our Involvement
Docere became part of “The Path” Incubator as one of the most promising
startups that is participating in this program,and we are looking forward to
work with DMZ.
7/14/20XX Docere 21
Our Early Investors
Baybars is willing to invest on our startup
Baybars Altuntaş is a Turkish Magnate,Angel Investor,Speaker and a Serial-Entrepreneur who is also chariman of WBAF.
Docere 22
Support from the
Albanian state
Mrs. Edona Bilali is the Minister of State for
Entrepreneurship Protection of Albania.
She has shown an extraordinary readiness and
support of the Albanian state for this startup,
and the possibilities of grants in the future.
Docere 23
Potential Investors
Donald Ziraldo
Samir Mane
Candian winemaker,Angel Investor and Member Order of the
Canada Albanian Billionaire,CEO of Balfin Group
Docere 24
WHAT’S NEXT?
Docere 25
7/14/20XX
What the future looks like?
7/14/20XX Docere 27
28
This is a project we did on
VR in the form of a Public
Speaking training made
with Unity
Enjoy it!
Docere 29
THANK YOU
Luka Lamaj
206-555-0146
[email protected]
www.docereapp.com
7/14/20XX Docere 30